Genetic, biochemical, and clinical features of chronic granulomatous disease
BH Segal, TL Leto, JI Gallin, HL Malech, SM Holland - Medicine, 2000 - journals.lww.com
Abbreviations used in this article: BMT, bone marrow transplantation; CDP, CCAAT
displacement protein; CGD, chronic granulomatous disease; EBV, Epstein-Barr virus; FAD, flavin …
displacement protein; CGD, chronic granulomatous disease; EBV, Epstein-Barr virus; FAD, flavin …
Aspergillosis
BH Segal - New England Journal of Medicine, 2009 - Mass Medical Soc
This review discusses important advances in fungal diagnostics and in the antifungal
armamentarium as applied to aspergillus species. Recent insights concerning host defenses …
armamentarium as applied to aspergillus species. Recent insights concerning host defenses …
Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and …
BH Segal, R Herbrecht, DA Stevens… - Clinical infectious …, 2008 - academic.oup.com
… Despite the low number of subjects, this study identified amphotericin B plus flucytosine
as the most effective regimen. In phase I/II studies in which patient accrual is limited, such …
as the most effective regimen. In phase I/II studies in which patient accrual is limited, such …
[PDF][PDF] 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren's syndrome: a consensus and data …
…, D Nelson, A Parke, S Pillemer, B Segal… - Arthritis & …, 2017 - Wiley Online Library
Objective To develop and validate an international set of classification criteria for primary
Sjögren's syndrome (SS) using guidelines from the American College of Rheumatology (ACR) …
Sjögren's syndrome (SS) using guidelines from the American College of Rheumatology (ACR) …
Revised definitions of invasive fungal disease from the European organization for research and treatment of cancer/invasive fungal infections cooperative group and …
…, A Restrepo, M Ruhnke, BH Segal… - Clinical infectious …, 2008 - academic.oup.com
Background. Invasive fungal diseases are important causes of morbidity and mortality. Clarity
and uniformity in defining these infections are important factors in improving the quality of …
and uniformity in defining these infections are important factors in improving the quality of …
Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America
…, KA Marr, VA Morrison, BH Segal… - Clinical infectious …, 2008 - JSTOR
… Refractory infection may respond to a change to another drug class (B-II) or to a combination
of agents (B-II). The role of combination therapy in the treatment of invasive aspergillosis as …
of agents (B-II). The role of combination therapy in the treatment of invasive aspergillosis as …
Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America
…, VA Morrison, MH Nguyen, BH Segal… - Clinical infectious …, 2016 - academic.oup.com
It is important to realize that guidelines cannot always account for individual variation among
patients. They are not intended to supplant physician judgment with respect to particular …
patients. They are not intended to supplant physician judgment with respect to particular …
Distribution of ADH2 and ALDH2 genotypes in different populations
…, R Lisker, YK Paik, F Rothhammer, N Saha, B Segal… - Human genetics, 1992 - Springer
The distribution of the human liver alcohol dehydrogenase, ADH 2 , and aldehyde dehydrogenase,
ALDH2, genotypes in 21 different populations comprising Mongoloids, Caucasoids, …
ALDH2, genotypes in 21 different populations comprising Mongoloids, Caucasoids, …
Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial
…, A Louie, P Ribaud, BH Segal… - Clinical infectious …, 2007 - academic.oup.com
Background . Invasive aspergillosis is an important cause of morbidity and mortality in
immunocompromised patients. Current treatments provide limited benefit. Posaconazole is an …
immunocompromised patients. Current treatments provide limited benefit. Posaconazole is an …
An interleukin (IL)-10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease
BM Segal, BK Dwyer, EM Shevach - The Journal of experimental …, 1998 - rupress.org
Cells of the innate immune system secrete cytokines early in immune responses that guide
maturing T helper (Th) cells along appropriate lineages. This study investigates the role of …
maturing T helper (Th) cells along appropriate lineages. This study investigates the role of …